Physician

Amanda Bucheit, MD

According to 2025 Medicare claims, Amanda Bucheit, MD (NPI: 1881711133) practices hematology/oncology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC (NPI: 1770664542; TIN: 742915297) and primary practice location at 78258-3989.

Bucheit's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 369 traditional Medicare patients, billed 130,892 HCPCS/CPT codes, and received $1,591,074 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 957 prescription claims across 170 beneficiaries totaling $2,347,288 in drug costs, led by Revlimid (Lenalidomide). 2021 DME data shows 31 claims. Open Payments data shows 42 records totaling $1,171. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $562,487 to $1,591,074. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $351,151 to $2,347,288. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$821K$1.6M2015 Medicare payment: $562,487 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $803,219 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,056,450 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,269,463 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,204,700 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,499,084 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,642,052 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,519,415 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,557,978 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,591,074 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201520868,712$562,487
2016242114,241$803,219
201727291,928$1,056,450
2018320132,126$1,269,463
201931582,681$1,204,700
2020287183,544$1,499,084
2021339187,913$1,642,052
2022382156,772$1,519,415
2023364120,716$1,557,978
2024369130,892$1,591,074

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.6M2015 Drug cost: $351,151 (USD; Tot_Drug_Cst)2016 Drug cost: $221,650 (USD; Tot_Drug_Cst)2017 Drug cost: $390,317 (USD; Tot_Drug_Cst)2018 Drug cost: $351,515 (USD; Tot_Drug_Cst)2019 Drug cost: $1,137,648 (USD; Tot_Drug_Cst)2020 Drug cost: $1,877,746 (USD; Tot_Drug_Cst)2021 Drug cost: $2,645,802 (USD; Tot_Drug_Cst)2022 Drug cost: $2,455,721 (USD; Tot_Drug_Cst)2023 Drug cost: $2,009,407 (USD; Tot_Drug_Cst)2024 Drug cost: $2,347,288 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201552457$351,151
201674615$221,650
201799777$390,317
2018107649$351,515
2019121727$1,137,648
20201501,212$1,877,746
20211541,087$2,645,802
20221771,135$2,455,721
20231591,084$2,009,407
2024170957$2,347,288

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.7K$5.4K2017 Medicare payment: $165 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,171 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $5,401 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,877 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R11$165
2018N/RN/RN/R
2019N/R37$3,171
2020N/R60$5,401
2021N/R31$2,877
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more170329$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more213306$63
80053Blood test, comprehensive group of blood chemicals311893$10
36415Insertion of needle into vein for collection of blood sample319791$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count310923$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide31868$691,225
LenalidomideLenalidomide23602$299,179
XtandiEnzalutamide21630$297,167
BesremiRopeginterferon Alfa-2b-Njft14392$234,983
JakafiRuxolitinib Phosphate13390$228,725

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.42$1,171Daiichi Sankyo Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amanda Bucheit, MD?

Tedicare shows public-source Medicare data for Amanda Bucheit, MD (NPI 1881711133), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Bucheit, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amanda Bucheit, MD?

Amanda Bucheit, MD is linked to SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC (billing NPI 1770664542) in the available physician profile data.

Does Amanda Bucheit, MD have Open Payments data?

Amanda Bucheit, MD has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.